- Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide
-
Kanno T, Matsui H, Akizawa Y, Usui H, Shozu M
- KMID: 2431234
- J Gynecol Oncol.
- 2018 Nov;29(6):e89.
- doi: 10.3802/jgo.2018.29.e89
OBJECTIVE: Highly effective chemotherapy for patients with low-risk gestational trophoblastic neoplasia (GTN) is associated with almost a 100% cure rate. However, 20%–30% of patients treated with chemotherapy need to change... -
- CITED
-
- Close
- SHARE
-
- Close
